China Life Insurance Lim...

OTC: CILJF · Real-Time Price · USD
2.90
-0.10 (-3.33%)
At close: Aug 15, 2025, 11:55 AM

China Life Insurance Income Statement

Financials in CNY. Fiscal year is undefined.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
61.19B 54.66B 190.66B 90.86B 86.66B 124.08B 531.6B 71.71B 366.22B 103.44B 184.28B 174.84B 341.71B 128.72B 176.55B 168.72B 377.19B
Cost of Revenue
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Gross Profit
61.19B 54.66B 190.66B 90.86B 86.66B 124.08B 531.6B 71.71B 366.22B 103.44B 184.28B 174.84B 341.71B 128.72B 176.55B 168.72B 377.19B
Operating Income
32.59B -8.44B -615M 3.22B 2.33B 1.2B -34.9B 1.49B 18.72B -6.67B -23M 4.08B 15.85B -19.12B 15.94B 17.08B 36.12B
Interest Income
n/a n/a n/a 29.54B 29.88B n/a 9.09B 54.62B 30.24B n/a 9B n/a 145M n/a 7.29B 7.29B n/a
Pretax Income
32.59B -8.44B 75.75B 17.52B 24.07B 4.29B -31.58B 5.63B 19.14B -3.81B 2.87B 8.73B 16.26B -2.08B 3.82B 6.3B 32.12B
Net Income
28.8B 2.41B 66.25B 17.63B 20.64B 4.9B -19.94B 8.8B 17.89B 965M 5.61B 10.26B 15.15B 2.42B 7.53B 12.39B 28.59B
Selling & General & Admin
1.61B -23.51B 12.78B 1.38B 1.34B 11.54B 9.38B 10.02B 1.38B 13.05B 9.12B 8.61B 9.45B 14.56B 8.77B 9.63B 9.29B
Research & Development
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Expenses
26.99B 86.61B 189.06B -29.69B -20.84B -18.12B -566.5B -70.22B -357.62B -122.38B -193.85B -179.37B -335.3B -40.76B -41.69B -32.03B -51.5B
Operating Expenses
28.6B 63.1B 190.66B 29.69B 20.84B 18.12B -566.5B -70.22B -347.5B -110.11B -184.3B -170.76B -325.86B 40.76B 41.69B 32.03B 51.5B
Interest Expense
n/a n/a 112.01B 86.76B 89.33B n/a n/a 14.92B 42.19B n/a n/a n/a 34.68B n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a 11.19B -190M n/a n/a n/a n/a n/a 2.47B n/a n/a n/a n/a 968M 968M n/a
Cost & Expenses
28.6B 63.1B 190.66B -72.49B -61.14B -88.44B 563.18B 66.08B 347.08B 107.25B 181.41B 166.11B 325.45B -130.93B -172.75B -162.45B -345.11B
Income Tax Expense
3.31B -11.48B 8.89B 3.11B 5.75B 586M -12.01B -3.55B 934M -5.15B -3.13B -1.94B 761M -3.11B -3.18B -1.78B 6.15B
Shares Outstanding (Basic)
28.24B 28.27B 28.27B 28.27B 28.27B 28.27B 28.27B 28.27B 28.27B 28.27B 28.26B 28.26B 27.44B 28.27B 28.26B 28.26B 28.26B
Shares Outstanding (Diluted)
28.24B 28.27B 28.27B 28.27B 28.27B 28.27B 28.27B 28.27B 28.27B 28.27B 28.26B 29.09B 27.44B 28.27B 28.26B 28.26B 28.26B
EPS (Basic)
1.02 0.09 2.34 0.62 0.73 0.17 -0.71 0.31 0.63 0.03 0.20 0.36 0.55 0.09 0.27 0.44 1.01
EPS (Diluted)
1.02 0.09 2.34 0.62 0.73 0.17 -0.71 0.31 0.63 0.03 0.20 0.35 0.55 0.09 0.27 0.44 1.01
EBITDA
n/a n/a -615M 4.36B 2.33B 2.34B n/a 1.49B 18.72B n/a -23M 4.08B 15.85B n/a n/a n/a n/a
EBIT
n/a n/a 187.76B 2.44B -4.73B 1.2B n/a 11.71B 44.46B n/a n/a 12.82B 32.17B n/a n/a n/a n/a
Depreciation & Amortization
n/a n/a n/a 1.14B -28.16B 1.14B 1.14B 1.15B 1.15B 1.19B -8.76B 1.23B 1.23B 1.21B 1.21B 1.21B 1.21B